The Venture Codex Logo

The Venture Codex

Autism Impact Fund

San Francisco, CA, United States

Overview

Investing in life science breakthroughs and innovative services for autism.

Founded

2021

Deals · 12mo

1

Links

WebsiteLinkedIn

Stage focus

Seed
Series A

Geographic focus

Germany
United States

Sector focus

—

Investment portfolio

9rounds
NAMEDATESIZE
Hopscotch Primary Care
Aug 2026Participated
$53 MSeries D
Imagine Pediatrics
Sep 2025Participated
$67 MSeries B
Cortica
Apr 2023Participated
$75 MOther Equity
SpectrumAi
Mar 2023Participated
$20 MSeries A
Floreo
Nov 2022Participated
$10 MSeries A
SpectrumAi
Jun 2022Participated
$9 MSeed
auticon
Feb 2022Led
$4 MOther Equity
Axial Biotherapeutics
Oct 2021Participated
$37 MSeries C
Joshin
Aug 2021Led
$3 MSeed
Hopscotch Primary Care
Aug 2026Participated
$53 MSeries D
Imagine Pediatrics
Sep 2025Participated
$67 MSeries B
Cortica
Apr 2023Participated
$75 MOther Equity
SpectrumAi
Mar 2023Participated
$20 MSeries A
Floreo
Nov 2022Participated
$10 MSeries A
SpectrumAi
Jun 2022Participated
$9 MSeed
auticon
Feb 2022Led
$4 MOther Equity
Axial Biotherapeutics
Oct 2021Participated
$37 MSeries C
Joshin
Aug 2021Led
$3 MSeed
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Autism Impact Fund: 9 funding rounds are recorded in the selected participation categories.All available history.
Autism Impact Fund: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed11
Series A02
Series B01
Series C+02
Other Equity11

Monthly Deal Activity

Autism Impact Fund: 9 deals are recorded across 63 months.All available history.
Autism Impact Fund: 9 deals are recorded across 63 months. All available history
MonthDeals
Aug '211
Sep '210
Oct '211
Nov '210
Dec '210
Jan '220
Feb '221
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '231
Apr '231
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '251
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '261
Sep '260
Oct '260

Sector Breakdown

Autism Impact Fund: Health & Life Sciences is the largest displayed sector by deal count (8 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Autism Impact Fund: Health & Life Sciences is the largest displayed sector by deal count (8 deals). All available history
SectorDeals
Health & Life Sciences8
Consumer & Lifestyle2
Education & Workforce1
AR/VR1
Professional Services1
Data, Analytics & IT1
Developer Tools1

Deal Size Distribution

Autism Impact Fund: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Autism Impact Fund: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M1
$10M-$25M2
$25M-$50M1
$50M-$100M3
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Autism Impact Fund: United States has the largest recorded deal count among the displayed regions (8 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Autism Impact Fund: United States has the largest recorded deal count among the displayed regions (8 deals). All available history
RegionDeals
United States8
Europe1
Autism Impact Fund: 20 co-investors are shown, with F-Prime Capital sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Autism Impact Fund: 20 co-investors are shown, with F-Prime Capital sharing 2 recorded deals. All available history
Co-investorShared deals
F-Prime Capital2
Frist Cressey Ventures2
Optum Ventures2
.406 Ventures1
8VC1
Ajax Health1
Alumni Ventures1
aMoon1
Anthemis1
Aperture Venture Partners1
Citi1
Cobalt Ventures1
Corundum Systems Biology1
CVS Health Ventures1
Deerfield Management1
Domain Associates1
Echo Health Ventures1
Felton Group1
K2 HealthVentures1
Leon Levine Foundation1

Investment Strategy

Autism Impact Fund: Led accounts for 22% and participating for 78% of round participation.All available history.
Autism Impact Fund: Led accounts for 22% and participating for 78% of round participation. All available history
CategoryDeals (count)Share (%)
Led222%
Participating778%
Autism Impact Fund: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Autism Impact Fund: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead150%
Co-led150%

Team

Ashok Srinivasan

Chief Scientific Officer

Brian A. O’Callaghan

Co-Founder

Christopher Male

Co-Founder & Managing Partner

Dan Tarman

Chief Communications Officer

Elizabeth Horn

Founding Partner

Robert Sarrazin

Chief Investment Officer & Managing Partner